|
시장보고서
상품코드
1983183
크론병 치료 시장 : 지역별(북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카)Crohns Disease Treatment Market, North America, Latin America, Europe, Asia Pacific, Middle East, Africa, By Geography |
||||||
크론병 치료 시장은 2026년에 128억 7,000만 달러로 추정되고 있으며, 2033년까지 171억 6,000만 달러에 달할 것으로 예상되고 있습니다. 2026-2033년에는 CAGR 4.2%로 성장할 것으로 전망되고 있습니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준연도 | 2025년 | 시장 규모(2026년) | 128억 7,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간의 CAGR(2025-2032년) | 4.20% | 예측 금액(2033년) | 171억 6,000만 달러 |
크론병은 소화관에 염증을 일으키는 만성 염증성장질환(IBD)의 일종입니다. 이 염증은 소장의 회장에서 대장의 결장까지 어디에서나 발생할 수 있습니다. 경증에서 중증의 크론병의 일반적인 증상으로는 복통, 식욕부진, 발열, 잦은 설사 등이 있습니다. 항문관의 염증으로 인한 찢어진 상처로 인해 직장 출혈이 나타나는 경우도 드물지만 있습니다. 크론병의 발병 요인으로는 유전적 요인, 염증 상태를 유발하는 자가면역 반응, 세균이나 바이러스와 같은 환경적 요인이 있습니다. 이 질병은 주로 15세에서 35세 사이의 사람들에게 영향을 미치며, 남녀 모두에게 발병합니다.
이 질병에 대한 특효약은 없지만, 환자에게는 다양한 치료법이 사용되어 증상 완화 및 장기적인 완화를 가져올 수 있습니다. 크론병 치료에 처방되는 항염증약, 면역억제제, 항생제 및 기타 염증을 억제하는 약물 등 여러 약물요법을 통해 장기적인 예후 개선을 기대할 수 있습니다.
시장 역학
북미와 유럽에서는 크론병과 같은 염증성장질환(IBD)의 유병률이 높아 시장 성장을 촉진할 것으로 예측됩니다. 예를 들어 2020년 12월 학술지 'Digestive Medicine Research'에 게재된 논문에 따르면 북미의 IBD 유병률은 2030년까지 약 400만 명에 달할 것으로 예측되고 있습니다. 이 정보원에 따르면 캐나다 데이터에 따르면 2018년 IBD 유병률은 10만 명당 725명이었으나, 2030년까지 981명으로 증가할 것으로 추산됩니다. 따라서 IBD의 유병률 증가는 예측 기간 중 시장 성장을 촉진할 것으로 예측됩니다.
이 보고서의 주요 특징
- 세계의 크론병 치료제 시장에 대해 조사 분석했으며, 2024년을 기준 연도로 하여 예측 기간(2025-2032년) 시장 규모와 연평균 성장률(CAGR)에 대해 조사 분석하여 전해드립니다.
- 또한 각 부문의 잠재적 매출 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 촉진 및 억제요인 및 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 업체들의 경쟁 전략 등에 대한 중요 인사이트을 제공합니다.
- 세계 크론병 치료제 시장의 주요 기업 개요을 기업 개요, 제품 포트폴리오, 주요 특징, 재무 성과, 전략 등의 매개 변수를 기반으로 정리하여 수록했습니다.
- 이 보고서의 인사이트을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 유형 업데이트, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있습니다.
- '세계 크론병 치료 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 크론병 치료제 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 용이하게 할 수 있습니다.
목차
제1장 분석 목적과 전제조건
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 크론병 치료 시장 : 약제 유형별(2026-2033년)
제5장 세계의 크론병 치료 시장 : 유통 채널별(2026-2033년)
제6장 세계의 크론병 치료 시장 : 지역별(2026-2033년)
제7장 경쟁 구도
제8장 섹션
KSA 26.04.20Crohn's Disease Treatment Market is estimated to be valued at USD 12.87 Bn in 2026 and is expected to reach USD 17.16 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 12.87 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 4.20% | 2033 Value Projection: | USD 17.16 Bn |
Crohn's disease is a form of chronic inflammatory bowel disease (IBD) that causes inflammation in the gastrointestinal tract. This inflammation can take place anywhere between the ileum of the small intestine to the colon of the large intestine. Common symptoms of Crohn's disease from mild to severe intensity include abdominal pain, reduced appetite, fever, and frequent diarrhea. Rectal bleeding is encountered in few cases due to fissures from inflammation at anal canal. Factors responsible for causing Crohn's disease include hereditary genes, autoimmune reaction that causes inflammatory condition, and environmental factors such as bacteria and virus. The disease majorly affects people falling between age group of 15-35 years and occurs in both males and females.
There exists no specific cure for the disease, however various therapies can be employed on patients that can help to reduce signs and symptoms of the disease as well as can bring long-term remission. Improvement in long-term prognosis can be achieved through several medications prescribed for the treatment of Crohn's disease that include anti-inflammatory drugs, immune system suppressers, antibiotics and other medication that helps to control inflammation.
Market Dynamics
The North America and Europe regions have high incidence of inflammatory bowel disease (IBD) such as Crohn's disease, which is expected to drive growth of market. For instance, according to an article published in the journal Digestive Medicine Research in December 2020, in North America, the prevalence of IBD is projected to affect approximately 4 million persons by 2030. According to the same source, data from Canada reported a prevalence of IBD at 725 per 100,000 in 2018, which is estimated to rise to 981 by 2030. Thus the increasing prevalence of IBD is expected to drive market growth over the forecast period.
Key features of the study
- This report provides in-depth analysis of the global crohn's disease treatment market, and provides market size (US$ Billion) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global crohn's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include AbbVie Inc., Janssen Biotech, Inc., Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Pfizer Inc., Eli Lilly and Company, Novartis AG, Sanofi, Takeda Pharmaceutical Company Limited, Mylan N.V., Amgen Inc., and AstraZeneca
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global crohn's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global crohn's disease treatment market
Market Segmentation
- By Drug Type
- Antibiotics
- Amino Salicylates
- Corticosteroids
- Immunomodulators
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- E-Commerce
- By Region
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East & Africa
- GCC Countries
- Israel
- Rest of Middle East & Africa
- Key Players
- AbbVie Inc.
- Janssen Biotech, Inc.
- Bristol-Myers Squibb Company
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Eli Lilly and Company
- Novartis AG
- Sanofi
- Takeda Pharmaceutical Company Limited
- Mylan N.V.
- Amgen Inc.
- AstraZeneca
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Market Trends
- PORTER's Five Forces Analysis
- Epidemiology
- New Product Launch
- Product Type Innovation
4. Global Crohn's Disease Treatment Market, By Drug Type, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Antibiotics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Amino Salicylates
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Immunomodulators
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
5. Global Crohn's Disease Treatment Market, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2026 - 2033
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- Retail Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
- E-Commerce
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2026-2033, (US$ Billion)
6. Global Crohn's Disease Treatment Market, By Region, 2026 - 2033, (US$ Billion)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2026-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2026 - 2033, (US$ Billion)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2026 - 2033, (US$ Billion)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2026 - 2033, (US$ Billion)
- North Africa
- Central Africa
- South Africa
7. Competitive Landscape
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Janssen Biotech, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boehringer Ingelheim GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- AstraZeneca
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
8. Section
- Research Methodology
- About Us
